Obituary: Jason S. Goldfeder, assistant professor of medicine, 45
Jason S. Goldfeder, MD, a revered teacher in the Division of Medical Education of the Department of Medicine at the School of Medicine, died Dec. 9, 2015, following a 12-year battle with amyotrophic lateral sclerosis (ALS).
Miller named Clayson Professor of Neurology
Timothy M. Miller, MD, PhD, a leading researcher in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), has been named the David Clayson Professor of Neurology at the School of Medicine. The professorship was established in 2001 through a bequest from David Clayson, PhD, to support innovative research into treatments for ALS.
Genetic errors linked to more ALS cases than scientists had thought
Genetic mutations may cause more cases of amyotrophic
lateral sclerosis (ALS) than scientists previously had realized, according
to researchers. Shown are study authors Janet Cady, a PhD candidate, and Matthew Harms, MD, assistant professor of neurology at the School of Medicine.
Heart drug may help treat ALS, mouse study shows
Digoxin, a medication that has been used to treat heart
failure, may be adaptable for the treatment of amyotrophic lateral sclerosis
(ALS), a progressive, paralyzing disease, suggests new research at
the School of Medicine.
ALS trial shows novel therapy is safe
An investigational treatment for an inherited form of
Lou Gehrig’s disease has passed an early phase clinical trial for
safety, researchers at the School of Medicine and Massachusetts General Hospital report. A mutated protein that causes an inherited form of Lou
Gehrig’s disease leads to clumps in the human cells, which are pictured.